Thursday, July 18, 2019 3:22:37 PM
(a) Grow early age replacement cells in the lab
(b) Use exosomes to deliver a signal for cells to temporarily express Telomerase (rejuvenates ends of DNA strands for endless copies)
(3) Insert those cells into the body where needed, along with the Small Molecule Cocktail iTR157 (turns on genes for temporary tissue regeneration vs scarring)
I guess this is their version of coming with all guns blazing. Take cells still capable of regeneration, program them to keep their Telomeres completely intact and drug them to continue to regenerate tissues even further.
And I'm also guessing they would cringe to hear the way I just explained things.
Recent AGE News
- AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results • GlobeNewswire Inc. • 03/22/2024 09:27:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/07/2024 09:49:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:47:08 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/07/2024 12:47:43 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:01:43 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/14/2024 05:15:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:05:20 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/05/2024 12:19:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:05:39 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/17/2024 09:19:13 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 01/16/2024 02:11:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:05:36 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/09/2024 09:16:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:02:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:25:54 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/13/2023 10:11:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:05:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:05:38 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/16/2023 09:01:20 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/15/2023 02:38:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 09:25:21 PM
- AgeX Therapeutics Reports Third Quarter 2023 Financial Results • Business Wire • 11/14/2023 09:05:00 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM